| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.06 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.097 | 0.06 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |